The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model (Q34221605)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model |
scientific article |
Statements
1 reference
The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model (English)
1 reference
Suraj Konnath George
1 reference
Deeksha Vishwamitra
1 reference
Roxsan Manshouri
1 reference
Ping Shi
1 reference
Hesham M Amin
1 reference
1 reference
1 reference
1 reference